FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308199199> ?p ?o ?g. }

• W4308199199 endingPage "7522" @default.
• W4308199199 startingPage "7522" @default.
• W4308199199 abstract "The SARS-CoV-2 non-structural protein 13 (nsp13) helicase is an essential enzyme for viral replication and has been identified as an attractive target for the development of new antiviral drugs. In detail, the helicase catalyzes the unwinding of double-stranded DNA or RNA in a 5′ to 3′ direction and acts in concert with the replication–transcription complex (nsp7/nsp8/nsp12). In this work, bioinformatics and computational tools allowed us to perform a detailed conservation analysis of the SARS-CoV-2 helicase genome and to further predict the druggable enzyme’s binding pockets. Thus, a structure-based virtual screening was used to identify valuable compounds that are capable of recognizing multiple nsp13 pockets. Starting from a database of around 4000 drugs already approved by the Food and Drug Administration (FDA), we chose 14 shared compounds capable of recognizing three out of four sites. Finally, by means of visual inspection analysis and based on their commercial availability, five promising compounds were submitted to in vitro assays. Among them, PF-03715455 was able to block both the unwinding and NTPase activities of nsp13 in a micromolar range." @default.
• W4308199199 created "2022-11-09" @default.
• W4308199199 creator A5003361347 @default.
• W4308199199 creator A5010139050 @default.
• W4308199199 creator A5011000737 @default.
• W4308199199 creator A5022120195 @default.
• W4308199199 creator A5023984688 @default.
• W4308199199 creator A5027151517 @default.
• W4308199199 creator A5037278019 @default.
• W4308199199 creator A5037425032 @default.
• W4308199199 creator A5045486560 @default.
• W4308199199 creator A5049875479 @default.
• W4308199199 creator A5056464448 @default.
• W4308199199 creator A5069733218 @default.
• W4308199199 creator A5080225362 @default.
• W4308199199 creator A5084481285 @default.
• W4308199199 date "2022-11-03" @default.
• W4308199199 modified "2023-09-25" @default.
• W4308199199 title "Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach" @default.
• W4308199199 cites W1519955970 @default.
• W4308199199 cites W1965280032 @default.
• W4308199199 cites W1982874561 @default.
• W4308199199 cites W2006927892 @default.
• W4308199199 cites W2018740887 @default.
• W4308199199 cites W2051381895 @default.
• W4308199199 cites W2062926294 @default.
• W4308199199 cites W2062941476 @default.
• W4308199199 cites W2080653934 @default.
• W4308199199 cites W2082677814 @default.
• W4308199199 cites W2094418371 @default.
• W4308199199 cites W2112898697 @default.
• W4308199199 cites W2130479394 @default.
• W4308199199 cites W2132412147 @default.
• W4308199199 cites W2159576923 @default.
• W4308199199 cites W2161572568 @default.
• W4308199199 cites W2244208996 @default.
• W4308199199 cites W2760133381 @default.
• W4308199199 cites W2981723136 @default.
• W4308199199 cites W3011701533 @default.
• W4308199199 cites W3025943349 @default.
• W4308199199 cites W3027236388 @default.
• W4308199199 cites W3043431476 @default.
• W4308199199 cites W3045645692 @default.
• W4308199199 cites W3080704959 @default.
• W4308199199 cites W3090894484 @default.
• W4308199199 cites W3092024794 @default.
• W4308199199 cites W3095467329 @default.
• W4308199199 cites W3095556560 @default.
• W4308199199 cites W3096064145 @default.
• W4308199199 cites W3101115975 @default.
• W4308199199 cites W3108303349 @default.
• W4308199199 cites W3117730334 @default.
• W4308199199 cites W3126162657 @default.
• W4308199199 cites W3132447912 @default.
• W4308199199 cites W3133012596 @default.
• W4308199199 cites W3135540980 @default.
• W4308199199 cites W3163058366 @default.
• W4308199199 cites W3163488943 @default.
• W4308199199 cites W3173207811 @default.
• W4308199199 cites W3174574879 @default.
• W4308199199 cites W3175059609 @default.
• W4308199199 cites W3175472437 @default.
• W4308199199 cites W3188488999 @default.
• W4308199199 cites W3192713004 @default.
• W4308199199 cites W3204448507 @default.
• W4308199199 cites W3214875087 @default.
• W4308199199 cites W4213003235 @default.
• W4308199199 cites W4220715066 @default.
• W4308199199 cites W4224212068 @default.
• W4308199199 cites W4225120401 @default.
• W4308199199 doi "https://doi.org/10.3390/molecules27217522" @default.
• W4308199199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36364347" @default.
• W4308199199 hasPublicationYear "2022" @default.
• W4308199199 type Work @default.
• W4308199199 citedByCount "3" @default.
• W4308199199 countsByYear W43081991992022 @default.
• W4308199199 countsByYear W43081991992023 @default.
• W4308199199 crossrefType "journal-article" @default.
• W4308199199 hasAuthorship W4308199199A5003361347 @default.
• W4308199199 hasAuthorship W4308199199A5010139050 @default.
• W4308199199 hasAuthorship W4308199199A5011000737 @default.
• W4308199199 hasAuthorship W4308199199A5022120195 @default.
• W4308199199 hasAuthorship W4308199199A5023984688 @default.
• W4308199199 hasAuthorship W4308199199A5027151517 @default.
• W4308199199 hasAuthorship W4308199199A5037278019 @default.
• W4308199199 hasAuthorship W4308199199A5037425032 @default.
• W4308199199 hasAuthorship W4308199199A5045486560 @default.
• W4308199199 hasAuthorship W4308199199A5049875479 @default.
• W4308199199 hasAuthorship W4308199199A5056464448 @default.
• W4308199199 hasAuthorship W4308199199A5069733218 @default.
• W4308199199 hasAuthorship W4308199199A5080225362 @default.
• W4308199199 hasAuthorship W4308199199A5084481285 @default.
• W4308199199 hasBestOaLocation W43081991991 @default.
• W4308199199 hasConcept C103637391 @default.
• W4308199199 hasConcept C103697762 @default.
• W4308199199 hasConcept C104317684 @default.
• W4308199199 hasConcept C10679952 @default.
• W4308199199 hasConcept C161223559 @default.

• next